Free/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3

Free/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3–10 ng/ml

Published:2006-12-13 Issue:3-4 Volume:38 Page:553-557
ISSN:0301-1623
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Elabbady Ahmed A.,Khedr Mahrousa M.

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s11255-006-6672-5.pdf

Reference17 articles.

1. Landis SH, Murray T, Bolden S and Wingo PA (1999). Cancer statistics, 1999. CA Cancer J Clin 49(31): 8–31

2. Sokoloff MH, Yang XJ, Fumo M, Mhoon D and Brendler CB (2004). Characterizing prostatic adenocarcinomas im men with a serum prostate specific antigen level of < 4.0 ng/ml. Br J Urol 93(4): 499–502

3. Stenman UH, Hakama M, Knekt P, Aromaa A, Teppo L and Leinonen J (1994). Serum concentration of prostate specific antigen and its complex with alpha 1-antichymotripsin before diagnosis of prostate cancer. Lancet 344: 1594–1598

4. Partin AW, Catalona WJ and Southwick PC (1996). Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology 48: 55

5. Akdas A, Cevik I, Turkeri L, Dalaman G and Emerk K (1997). The role of free prostate- specific antigen in the diagnosis of prostate cancer. Br J Urol 79(6): 920–923

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?;BJU International;2020-09-26

2. Promoter polymorphisms of the PCA3 gene are not associated with its overexpression in prostate cancer patients;Journal of Genetics;2020-06-04

3. Association of Gleason score with PSA Values and Serum Testosterone Levels Measured Prior To Prostate Biopsy;JCPSP-J COLL PHYSICI;2020

4. Optimal threshold of the prostate health index in predicting aggressive prostate cancer using predefined cost–benefit ratios and prevalence;International Urology and Nephrology;2019-12-24

5. Letter to the Editor on: Prostate-specific antigen density is predictive of outcome in suboptimal prostate seed brachytherapy;Brachytherapy;2017-05